Concepedia

John Ronan

JR

Statistics

Publications

11

Citations

1.6K

H-Index

11

Active since

1992

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Bath

Diabetes Australia

Ionis Pharmaceuticals (United States)

John Ronan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, physiology, and pharmacology.

Top concepts

MedicinePhysiologyPharmacologyHealthObesityMetabolismMetabolic SyndromeDiabetesBiochemistryEndocrinology

Publications per year

1992–2011

11

Publications

11

Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance

Stacey Conarello, Zhihua Li, John Ronan et al. · Proceedings of the National Academy of Sciences · 2003 · 348 citations · Full text

Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1

Guoqiang Jiang, Zhihua Li, Franklin Liu et al. · Journal of Clinical Investigation · 2005 · 255 citations · Full text

Pharmacotherapy, Fatty Liver Disease, Obesity +20

Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1

Guoqiang Jiang, Zhihua Li, Franklin Liu et al. · Journal of Clinical Investigation · 2005 · 236 citations

Pharmacotherapy, Fatty Liver Disease, Caloric Restriction +22

Impaired Wound Contraction in Stromelysin-1–Deficient Mice

Kelli M. Bullard, Leif R. Lund, John S. Mudgett et al. · Annals of Surgery · 1999 · 233 citations · Full text

Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia

Stacey Conarello, Guoqiang Jiang, James Mu et al. · Diabetologia · 2006 · 214 citations · Full text

Obesity, Metabolic Syndrome, Energy Homeostasis +11

1–5 of 11